Usefulness of HeberFERON® in patients with basal cell carcinoma
Introduction: The basal cell carcinoma is the most frequent epithelial neoplasm, because it constitutes 60-80 % of all the cutaneous cancers. Objective: To determine the answer to HeberFERON® in patients with basal cell carcinoma. Methods: An observational, descriptive and longitudinal study of...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Centro Provincial de Información de Ciencias Médicas
2021-11-01
|
| Series: | Medisan |
| Subjects: | |
| Online Access: | http://www.medisan.sld.cu/index.php/san/article/view/3867 |